Patents by Inventor Nathan C. Crouther

Nathan C. Crouther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240358284
    Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
    Type: Application
    Filed: July 5, 2024
    Publication date: October 31, 2024
    Inventors: Marc B. TAUB, Nathan C. CROUTHER, Jai KARAN
  • Publication number: 20240358919
    Abstract: Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.
    Type: Application
    Filed: July 5, 2024
    Publication date: October 31, 2024
    Inventors: Erwin S. BUDIMAN, Gary A. HAYTER, Nathan C. CROUTHER, Marc B. TAUB, Wesley Scott HARPER, Charles WEI
  • Publication number: 20240350727
    Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surf ace of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.
    Type: Application
    Filed: November 30, 2023
    Publication date: October 24, 2024
    Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
  • Patent number: 12121350
    Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: October 22, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Marc B. Taub, Nathan C. Crouther, Jai Karan
  • Publication number: 20240312613
    Abstract: The present disclosure includes methods, devices and systems for establishing a connection between a medical device and a remote computing device, receiving an upgrade command at the medical device, storing a current version of persistent data and a current version of executable code in a first storage area of the medical device, transmitting at least the current version of the persistent data to the remote computing device, receiving a second format of the current version of the persistent data and an upgraded version of executable code at the medical device, storing the second format of the current version of the persistent data and the upgraded version of the executable code in a second storage area of the medical device, and executing the upgraded version of the executable code with the second format of the current version of the persistent data.
    Type: Application
    Filed: October 19, 2023
    Publication date: September 19, 2024
    Inventors: Saeed Nekoomaram, Nathan C. Crouther
  • Publication number: 20240225559
    Abstract: A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.
    Type: Application
    Filed: March 20, 2024
    Publication date: July 11, 2024
    Inventors: Erwin Satrya BUDIMAN, Kenneth J. DONIGER, Timothy C. DUNN, Nathan C. CROUTHER, Glenn BERMAN, Howard A. WOLPERT
  • Patent number: 11963801
    Abstract: A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: April 23, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Erwin S. Budiman, Kenneth J. Doniger, Timothy C. Dunn, Nathan C. Crouther, Glenn Berman, Howard A. Wolpert
  • Publication number: 20240122552
    Abstract: Generally, methods of analyte monitoring management, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data and analyzing the analyte measurement data for health related parameters. Recommendations are determined for creating or modifying a treatment program based on the analysis, and provided within a user-interface that enables a user to create or modify the treatment program. Further, generally, methods of for managing analyte measurement data, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data that represent data collected over a time period, and analyzing the analyte measurement data for analyte episodes within that time period. Threshold based episodes and/or rate-of-change based episodes may be determined.
    Type: Application
    Filed: October 26, 2023
    Publication date: April 18, 2024
    Inventors: Nathan C. Crouther, Timothy C. Dunn
  • Patent number: 11872370
    Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surface of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: January 16, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
  • Publication number: 20240000348
    Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
    Type: Application
    Filed: September 18, 2023
    Publication date: January 4, 2024
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Marc B. TAUB, Nathan C. CROUTHER, Jai KARAN
  • Patent number: 11854693
    Abstract: The present disclosure includes methods, devices and systems for establishing a connection between a medical device and a remote computing device, receiving an upgrade command at the medical device, storing a current version of persistent data and a current version of executable code in a first storage area of the medical device, transmitting at least the current version of the persistent data to the remote computing device, receiving a second format of the current version of the persistent data and an upgraded version of executable code at the medical device, storing the second format of the current version of the persistent data and the upgraded version of the executable code in a second storage area of the medical device, and executing the upgraded version of the executable code with the second format of the current version of the persistent data.
    Type: Grant
    Filed: November 21, 2022
    Date of Patent: December 26, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Saeed Nekoomaram, Nathan C. Crouther
  • Patent number: 11832973
    Abstract: Generally, methods of analyte monitoring management, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data and analyzing the analyte measurement data for health related parameters. Recommendations are determined for creating or modifying a treatment program based on the analysis, and provided within a user-interface that enables a user to create or modify the treatment program. Further, generally, methods of for managing analyte measurement data, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data that represent data collected over a time period, and analyzing the analyte measurement data for analyte episodes within that time period. Threshold based episodes and/or rate-of-change based episodes may be determined.
    Type: Grant
    Filed: February 9, 2021
    Date of Patent: December 5, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Nathan C. Crouther, Timothy C. Dunn
  • Patent number: 11793936
    Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surface of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: October 24, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
  • Patent number: 11793427
    Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: October 24, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Marc B. Taub, Nathan C. Crouther, Jai Karan
  • Publication number: 20230191026
    Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surface of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.
    Type: Application
    Filed: February 14, 2023
    Publication date: June 22, 2023
    Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
  • Publication number: 20230199069
    Abstract: Systems, devices, and methods are provided for the management of multiple sensor control devices and/or multiple reader devices in an in vivo analyte monitoring environment, and also for resolving conflicts when merging data collected by different reader devices.
    Type: Application
    Filed: February 14, 2023
    Publication date: June 22, 2023
    Inventors: Mark Sloan, Nathan C. Crouther, Glenn Berman, Gil Porat, Michael R. Love
  • Publication number: 20230092591
    Abstract: The present disclosure includes methods, devices and systems for establishing a connection between a medical device and a remote computing device, receiving an upgrade command at the medical device, storing a current version of persistent data and a current version of executable code in a first storage area of the medical device, transmitting at least the current version of the persistent data to the remote computing device, receiving a second format of the current version of the persistent data and an upgraded version of executable code at the medical device, storing the second format of the current version of the persistent data and the upgraded version of the executable code in a second storage area of the medical device, and executing the upgraded version of the executable code with the second format of the current version of the persistent data.
    Type: Application
    Filed: November 21, 2022
    Publication date: March 23, 2023
    Inventors: Saeed Nekoomaram, Nathan C. Crouther
  • Patent number: 11563812
    Abstract: Systems, devices, and methods are provided for the management of multiple sensor control devices and/or multiple reader devices in an in vivo analyte monitoring environment, and also for resolving conflicts when merging data collected by different reader devices.
    Type: Grant
    Filed: May 5, 2022
    Date of Patent: January 24, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Mark Sloan, Nathan C. Crouther, Glenn Berman, Gil Porat, Michael R. Love
  • Publication number: 20220287652
    Abstract: A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.
    Type: Application
    Filed: March 18, 2022
    Publication date: September 15, 2022
    Inventors: Erwin S. Budiman, Gary A. Hayter, Kenneth J. Doniger, Timothy C. Dunn, Nathan C. Crouther, Glenn Berman, Howard A. Wolpert
  • Patent number: D1030780
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: June 11, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Erwin S. Budiman, Gary A. Hayter, Kenneth J. Doniger, Timothy C. Dunn, Nathan C. Crouther, Glenn Berman, Howard A. Wolpert